Introduction
The Axumin PET scan is an advanced imaging test used to detect recurrent prostate cancer. Utilizing a specialized radioactive tracer (fluciclovine F-18), this scan identifies areas of abnormal metabolic activity, often before they are visible on other imaging tests. At Crossroads Urology, we offer Axumin PET scans to provide precise and early detection of prostate cancer recurrence.
Purpose
The Axumin PET scan is used to:
- Detect recurrent prostate cancer in patients with a rising PSA after treatment.
- Pinpoint areas of metastatic disease for targeted treatment planning.
- Guide biopsies or surgical interventions for recurrent cancer.
Procedure
During the Axumin PET scan:
- The patient receives an injection of the Axumin tracer into a vein.
- After a short waiting period, the patient lies on a scanning table.
- A PET-CT scanner captures detailed images of the tracer’s distribution in the body.
Areas of abnormal tracer uptake are analyzed for signs of recurrent cancer.
Procedure
- Patients should fast for at least 4 hours before the scan.
- Avoid strenuous activity for 24 hours before the test.
- Inform the provider of any medications or medical conditions.
Risks and Considerations
- The Axumin tracer involves minimal radiation exposure, similar to other PET scans.
- Rare allergic reactions to the tracer may occur.
At Crossroads Urology, we ensure the procedure is safe and comfortable for all patients.
Results
- Results are interpreted by a radiologist and reviewed with the patient during a follow-up visit.
- Findings guide treatment decisions, such as additional imaging, radiation therapy, or surgery.
Conclusion
The Axumin PET scan is a cutting-edge tool for detecting recurrent prostate cancer, offering early and precise diagnosis. At Crossroads Urology, we provide this advanced imaging technology to deliver superior care. Contact us today to learn more about Axumin PET scans and schedule your evaluation.